Nuvalent, Inc (NASDAQ:NUVL) Strengthens Balance Sheet Ahead Of Near-Term Clinical Catalysts
![]() |
Nuvalent enters the next phase with a larger cash position and multiple clinical data inflection points on the calendar, presenting a near-term focus on capital efficiency and clinical readouts. |









